1,573
Views
46
CrossRef citations to date
0
Altmetric
Editorial

Norovirus vaccine development: next steps

&
Pages 1023-1025 | Published online: 09 Jan 2014
 

Financial & competing interests disclosure

RL Atmar has received grant support from Ligocyte Pharmaceuticals, Inc. MK Estes has a patent on the use of norovirus virus-like particles as a vaccine and serves as a consultant to Ligocyte Pharmaceuticals, Inc. Support for the manuscript was received in part from the NIH (P01 AI 57788, P30 DK56336), the United States Department of Agriculture (USDA 2011-68003-30395) and the John S. Dunn Research Foundation. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.